Preliminary Scientific Program
| Wednesday, 31 March 2027 | ||||||
| 11:00-14:30 | Pre-Conference Workshops
|
|||||
| 12:00 |
Registration Opens |
|||||
| 15:00-16:50 |
2nd International Symposium Opening |
|||||
| 15:00-15:20 | Welcome: Introduction to Spasticity X and The International Spasticity Society |
|||||
| 15:20-15:40 | Neurophysiologic Prediction of Poststroke Spasticity |
|||||
| 15:40-16:00 | Lesion Characteristics & Structural Disconnectome Predicting Spasticity |
|||||
| 16:00-16:20 | Precision Spasticity Management: Matching Treatment to Patient Phenotype |
|||||
| 16:20-16:40 | Is Spasticity Maladaptive Plasticity? |
|||||
| 16:40-16:50 | Q & A |
|||||
| 16:50-17:20 |
Break |
|||||
| 17:20-19:30 |
General Session 2 |
|||||
| 17:20-17:40 | Revisiting the Role of Surface Electromyography in Spasticity Assessment |
|||||
| 17:40-18:00 | Electromyographic Correlates of Ultrasonographic Findings in Spasticity |
|||||
| 18:00-18:20 | Clinical Correlates of Ultrasonographic Observations to Optimize Outcomes in Spasticity Management |
|||||
| 18:20-18:40 | Ultrasonographic Assessment of Trunk and Proximal Limb Muscles |
|||||
| 18:40-18:50 | Q & A |
|||||
| 18:50-19:20 | ISS Lifetime Achievement Award Lecture |
|||||
| 19:20-19:30 | Q & A and Presentation of Award |
|||||
| 19:30-21:30 | Welcome Reception and Networking • Exhibits and Poster Hall Open |
|||||
| Thursday, 1 April 2027 | ||||||
| 08:00-10:05 |
General Session 3 |
|||||
| 08:00-08:15 | Opening Remarks |
|||||
| 08:15-08:35 | Transition of Spasticity care from Pediatrics to Adults: Challenges and Solutions |
|||||
| 08:35-08:55 | Postural Stability to Assess Outcomes of Botulinum Toxin Treatment of Spasticity in Children with Cerebral Palsy |
|||||
| 08:55-09:15 | Non-Invasive Assessment of Muscle Spasticity in Children Using Near-infrared Spectroscopy |
|||||
| 09:15-09:25 | Q & A |
|||||
| 09:25-10:05 | Debate: Pediatric Topic TBD |
|||||
| 10:05-10:50 |
Break • Educational Theatre • Exhibit and Poster Hall Open |
|||||
| 10:50-12:00 |
General Session 4 |
|||||
| 10:50-11:10 | Early Recognition and Intervention for Poststroke Spasticity (The American Heart Association Stroke Council Statement) |
|||||
| 11:10-11:30 | The Benefits of Early Intervention Using Botulinum Toxin |
|||||
| 11:30-11:50 | Does Spasticity Really Begin Early? |
|||||
| 11:50-12:00 | Q & A |
|||||
| 12:00-14:00 |
Lunch • Industry-Sponsored Session • Exhibit and Poster Hall Open |
|||||
| 14:00-15:30 | Parallel Session 1 Focus on Persons With the Lived Experience of Spasticity |
Parallel Session 2 Gait |
||||
| 14:00-14:20 | Aligning Minds in Spasticity Care |
Instrumented Assessment of Spastic Gait |
||||
| 14:20-14:40 | Patient and Caregiver Burden and The Lived Experience of Spasticity |
Spasticity’s Impact on Gait Speed |
||||
| 14:40-15:00 | The Spasticity Syndrome and its Multimodal Management are a Patient-Centric Approach |
Hemiplegic Spastic Gait and the Effect of Phenol Neurolysis |
||||
| 15:00-15:20 | Patient Perspectives on Adherence to Botulinum Toxin Therapy in Spasticity |
Effectiveness of Botulinum Toxin A on Gait and Fatigue in Persons With Multiple Sclerosis |
||||
| 15:20-15:30 | Q & A |
Q & A |
||||
| 15:30-16:15 | Break • Educational Theatre • Exhibit and Poster Hall Open | |||||
| 16:15-17:45 | Parallel Session 3 Spinal Origin Spasticity |
Parallel Session 4 Neuro-Orthopedics |
||||
| 16:15-16:35 | Spasticity After Traumatic Spinal Cord Injury: Implications for Recovery |
Contemporary Management of Equinovarus Deformity |
||||
| 16:35-16:55 | Reticulospinal Contributions to Spinal-Origin Spasticity |
Management of Post-Stroke Flexed Elbow Deformity |
||||
| 16:55-17:15 | Multifocal Spasticity Management in Persons with Spinal Cord Injuries: Focus on Proximal Musculature |
Percutaneous Tenotomy for Spasticity Management |
||||
| 17:15-17:35 | Bone Health and Spasticity After a Spinal Cord Injury |
Emerging Surgical Interventions for Spasticity |
||||
| 17:35-17:45 | Q & A |
Q & A |
||||
| Friday, 2 April 2027 | ||||||
| 08:30-12:00 | Parallel Session 5 Spasticity Assessment and Therapeutic Exercise Modalities |
Parallel Session 6 Neurolysis and Other Procedures |
||||
| 08:30-08:40 | Opening Remarks |
Opening Remarks |
||||
| 08:40-09:00 | The Complexities of Conceptualizing, Defining, and Measuring Spasticity |
Developments in Cryoneurolysis |
||||
| 09:00-09:20 | Exercise and Spasticity |
Long-term Outcome of Cryoneurolysis |
||||
| 09:20-09:40 | Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke |
Appropriate Use of Diagnostic Nerve Block |
||||
| 09:40-10:00 | Impact of Pre-Conditioning Serial Casting on Botulinum Toxin Therapy |
Dry Needling |
||||
| 10:00-10:10 | Q & A |
Q & A |
||||
| 10:10-10:55 | Break • Educational Theatre • Exhibit and Poster Hall Open | |||||
| 10:55-12:05 | Parallel Session 7 Technology Forum: Assessment and Treatment |
Parallel Session 8 Neurolysis and Other Procedures |
||||
| 10:55-11:15 | Robotics for Spasticity Assessment and Treatment |
Opening Remarks |
||||
| 11:15-11:35 | Wearable Sensor Technology |
Debate: Phenol Neurolysis or Cryoneurolysis? |
||||
| 11:35-11:55 | Extracorporeal Shock Wave Therapy for Post-Stroke Spasticity |
|||||
| 11:55-12:05 | Q & A |
Q & A |
||||
| 12:05-14:00 | Lunch • Industry-Sponsored Session • Exhibit and Poster Hall Open | |||||
| 14:00-15:30 | Parallel Session 9 Artificial Intelligence |
Parallel Session 10 Botulinum Toxins I |
||||
| 14:00-14:20 | The Basics of Artificial Intelligence |
Short- and Long-Acting Botulinum Toxins |
||||
| 14:20-14:40 | Artificial Intelligence for Spasticity Management |
Botulinum Toxin in Pain-Related Post-Stroke Limb Spasticity |
||||
| 14:40-15:00 | Natural Language Processing and Machine Learning in Spasticity Management |
Unpleasant Sensations in Spasticity & the Modulatory Role of Botulinum Toxin |
||||
| 15:00-15:20 | Machine Learning Algorithm Prediction in Spasticity Assessment |
Use of Botulinum Toxin as a Treatment of Hemiplegic Shoulder Pain Syndrome |
||||
| 15:30-16:15 | Break • Educational Theatre • Exhibit and Poster Hall Open | |||||
| 16:15-17:45 | Parallel Session 11 Oral Presentations |
Parallel Session 12 Neuromodulation |
||||
| 16:15-16:35 | Oral Presentation 1 Oral Presentation 2 |
European Expert Consensus on Improving Patient Selection for Chemodenervation and Intrathecal Therapy |
||||
| 16:35-16:55 | Oral Presentation 3 Oral Presentation 4 |
Revisiting the Role of Intrathecal Therapies in Comprehensive Spasticity Management |
||||
| 16:55-17:15 | Oral Presentation 5 Oral Presentation 6 |
Advanced Techniques to Optimize Intrathecal Therapies for Spasticity |
||||
| 17:15-17:35 | Oral Presentation 7 Oral Presentation 8 |
Radiofrequency Interventions for Spasticity |
||||
| 17:35-17:45 | Q & A |
Q & A |
||||
| Saturday, 3 April 2027 | ||||||
| 09:00-10:30 | Parallel Session 11 Botulinum Toxins II |
Parallel Session 12 Neuromodulation II |
||||
| 09:00-09:20 | Managing the Patient with Concurrent Multiple Indications for Botulinum Toxin |
Repetitive Magnetic Stimulation for Treating Upper Limb Spasticity After Stroke |
||||
| 09:20-09:40 | Effects of Increasing Botulinum Toxin Doses on Gait |
Electrical Stimulation Therapy for Post-Stroke Spasticity |
||||
| 09:40-10:00 | Safety and Efficacy of Newer Botulinum Toxins in the Treatment of Post-Stroke Upper Limb Spasticity |
High-Frequency Epidural Electrical Stimulation in Managing Spasticity in Spinal Cord Injury |
||||
| 10:00-10:20 | The Impact of Botulinum Toxins on Abnormal Flexor Synergies |
Pre- and Postsynaptic Inhibition of Spinal Spasticity by Transcutaneous Spinal Cord Stimulation |
||||
| 10:20-10:30 | Q & A |
Q & A |
||||
| 10:30-10:50 | Break | |||||
| 10:50-13:00 | General Session 5 Focus on Muscle in Spasticity Best Paper and Poster Awards |
|||||
| 10:50-10:55 | Muscle Changes in Spasticity |
|||||
| 10:55-11:15 | Relationship Between Spasticity, Muscle Stiffness and Fibrosis – Insights From Treatment With Hyaluronidase |
|||||
| 11:15-11:35 | Impact of Long-Term Botulinum Toxin A Treatment on Muscle Morphology and Stiffness |
|||||
| 11:35-11:55 | Muscle Type-Specific Effects of Botulinum Toxin on Muscle Growth and Contractile Function |
|||||
| 11:55-12:15 | Direct Myosin Inhibition as a Drug Target for Treating Spasticity |
|||||
| 12:15-12:35 | The Effect of Excitation-Contraction Coupling Inhibitors on the Action of Botulinum Neurotoxins |
|||||
| 12:35-12:45 | Q & A |
|||||
| 12:45-12:55 | Best Oral Paper and Poster Awards Presentation |
|||||
| 12:55-13:00 | Closing Remarks | |||||
